Eli Lilly (LLY 2.45%) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like ...
There's still a lot to like about Eli Lilly (LLY) stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its fourth-quarter sales guidance ...
Anticipated sales of Mounjaro and Zepbound came up short of expectations, the company said, prompting its stock to drop Tuesday.
Eli Lilly stock (NYSE: LLY) fell over 6% on Tuesday, January 14, after it announced that the sales of its obesity drugs are seeing slower than anticipated ...
Shares plunged 7% after management said demand for its popular GLP-1 drugs did not meet expectations.
2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidance.
Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second ...
U.S. equities were slightly lower at midday after initially rising following the December report on producer prices.